TLPH logo

TLPH
Acelrx Pharmaceuticals Inc

15,369
Mkt Cap
$42.3M
Volume
43,882.00
52W High
$1.57
52W Low
$0.38
PE Ratio
-2.71
TLPH Fundamentals
Price
$0.8151
Prev Close
$0.8177
Open
$0.8051
50D MA
$0.8115
Beta
0.76
Avg. Volume
142,227.12
EPS (Annual)
-$0.3369
P/B
2.21
Rev/Employee
$2,333.33
$34.47
Loading...
Loading...
News
all
press releases
Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update
Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update PR Newswire SAN MATEO...
News Placeholder
More News
News Placeholder
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026 Talphera to Host First Quarter Financial Results and Corporate Update Call and...
News Placeholder
Talphera (NASDAQ:TLPH) CEO Acquires $125,852.90 in Stock
Talphera, Inc. (NASDAQ:TLPH - Get Free Report) CEO Vincent Angotti purchased 213,310 shares of the firm's stock in a transaction that occurred on Friday, March 13th. The shares were acquired at an average price of $0.59 per share, with a total value of $125,852.90. Following the purchase, the chief...
News Placeholder
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 PR Newswire SAN MATEO, Calif., March 25...
News Placeholder
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate...
News Placeholder
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026 Talphera to Host Virtual Investor & Analyst Event to...
News Placeholder
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial PR Newswire SAN MATEO...
News Placeholder
Insider Buying: Talphera (NASDAQ:TLPH) CEO Buys 105,364 Shares of Stock
Talphera, Inc. (NASDAQ:TLPH - Get Free Report) CEO Vincent Angotti acquired 105,364 shares of the business's stock in a transaction that occurred on Thursday, February 12th. The stock was bought at...
News Placeholder
Talphera (NASDAQ:TLPH) Stock Price Down 2.7% - Here's Why
Talphera (NASDAQ:TLPH) Stock Price Down 2.7% - Here's What Happened...
News Placeholder
Talphera (NASDAQ:TLPH) Trading 3.2% Higher - Here's Why
Talphera (NASDAQ:TLPH) Shares Up 3.2% - Here's What Happened...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available